[Effectiveness and safety of percutaneous repair systems for the treatment of tricuspid valve insufficiency]

García Carpintero EE, Rodríguez Rojas L, Martín Saborido C
Record ID 32018016168
Spanish
Original Title: Efectividad y seguridad de los sistemas de reparación y reemplazo percutáneo para el tratamiento de insuficiencia de la válvula tricúspide
Authors' objectives: Analysis of safety, efficacy and effectiveness of percutaneous tricuspid valve repair and replacement versus conventional surgery or optimal medical treatment
Authors' results and conclusions: The search identified 34 articles, which were added to 20 publications included in the previous report, while a June 2026 update identified five additional publications. The evidence covered annuloplasty, transcatheter edge-to-edge repair, spacer and leaflet-approximation technologies, as well as orthotopic and heterotopic replacement devices. Overall, transcatheter repair devices demonstrated relevant reductions in TR severity, together with improvements in NYHA functional class, exercise capacity and quality of life. Edge-to-edge systems, particularly TriClip and PASCAL, currently have the greatest clinical maturity among repair technologies. Randomised trials showed TriClip to be superior to medical therapy in reducing TR and improving functional outcomes. Among orthotopic replacement technologies, EVOQUE has the most robust evidence and achieved almost complete elimination of TR in most treated patients, accompanied by clinically meaningful improvements in functional status and quality of life. LuX-Valve and NaviGate also showed favourable outcomes, although evidence is mainly derived from observational studies. Heterotopic devices showed more limited functional benefits, while SAPIEN raised substantial safety concerns. Overall, transcatheter tricuspid interventions represent a promising therapeutic alternative, particularly for patients at high surgical risk. Nevertheless, heterogeneity among studies, the predominance of single-arm designs and limited sample sizes prevent definitive conclusions regarding the relative superiority of individual strategies. Larger comparative studies with longer follow-up, together with economic and organisational evaluations, are required to determine the optimal positioning of these technologies and improve patient selection
Authors' methods: A systematic literature review was conducted using Medline, Embase and the Cochrane Library. Studies including adults with moderate or severe TR treated with transcatheter repair or replacement devices were considered. Eligible designs included randomised controlled trials, comparative studies, cohort studies and single-arm trials.
Details
Project Status: Completed
Year Published: 2026
URL for published report: https://hdl.handle.net/20.500.12105/27780
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Spain
MeSH Terms
  • Tricuspid Valve Insufficiency
  • Heart Valve Prosthesis Implantation
  • Heart Valve Prosthesis
  • Percutaneous Coronary Intervention
Keywords
  • Tricuspid Regurgitation
  • Percutaneous Tricuspid
  • Reparation
  • Replacement
Contact
Organisation Name: Agencia de Evaluacion de Tecnologias Sanitarias
Contact Address: Instituto de Salud "Carlos III", Calle Sinesio Delgado 6, Pabellon 4, 28029 Madrid, Spain. Tel: +34 9 1 822 2005; Fax: +34 9 1 387 7841;
Contact Name: Esther E. García Carpintero
Contact Email: eegarcia@isciii.es
Copyright: Agencia de Evaluacion de Tecnologias Sanitarias
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.